Keyword Analysis & Research: remdesivir indications other than covid

nih.gov

https://www.covid19treatmentguidelines.nih.gov/therapies/antiviral-therapy/remdesivir/

Remdesivir is available through an FDA EUA for the treatment of COVID-19 in hospitalized pediatric patients weighing 3.5 kg to <40 kg or aged <12 years and weighing ≥3.5 kg or in nonhospitalized pediatric patients with mild to moderate COVID-19 and at high risk for disease progression. There are insufficient data on … For the Panel’s recommendations and information on the clinical efficacy of remdesivir in high-risk, nonhospitalized patients with mild to moderate COVID-19 and on the order of preference for outpatient antiviral therapies, see Therapeutic Management of Nonhospitalized Adults With CO…

Remdesivir is available through an FDA EUA for the treatment of COVID-19 in hospitalized pediatric patients weighing 3.5 kg to <40 kg or aged <12 years and weighing ≥3.5 kg or in nonhospitalized pediatric patients with mild to moderate COVID-19 and at high risk for disease progression. There are insufficient data on …

For the Panel’s recommendations and information on the clinical efficacy of remdesivir in high-risk, nonhospitalized patients with mild to moderate COVID-19 and on the order of preference for outpatient antiviral therapies, see Therapeutic Management of Nonhospitalized Adults With CO…

DA: 7 PA: 96 MOZ Rank: 84

drugs.com

https://www.drugs.com/mtm/remdesivir.html

May 12, 2022 · Remdesivir is used to treat adults and children at least 28 days and older who weigh at least 7 pounds (3 kilograms) with positive results for COVID-19 who are: in a hospital; …

DA: 80 PA: 62 MOZ Rank: 34

uptodate.com

https://www.uptodate.com/contents/remdesivir-drug-information

Nov 23, 2020 · Use: Labeled Indications COVID-19: Treatment of laboratory-confirmed COVID-19 in adult and pediatric patients (12 years of age and older weighing at least 40 kg) who …

DA: 63 PA: 64 MOZ Rank: 37

nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224666/

May 22, 2021 · While remdesivir may still have some clinical benefits during the first few days of treatment of COVID-19, inhibition of virus replication was no longer of clinical relevance a few … Author: Lars Dölken, August Stich, Christoph D. Spinner Published: 2021 Jun Publish Year: 2021

Author: Lars Dölken, August Stich, Christoph D. Spinner

Published: 2021 Jun

Publish Year: 2021

DA: 88 PA: 90 MOZ Rank: 88

nih.gov

https://pubmed.ncbi.nlm.nih.gov/34843589/

Methods: We will conduct a systematic review of randomised trials comparing remdesivir to placebo or standard of care in any setting. We will include trials regardless of the severity of … Author: Asger Sand Paludan-Müller, Asger Sand Paludan-Müller, Andreas Lundh, Andreas Lundh, Matthew J Page, ... Publish Year: 2021

Author: Asger Sand Paludan-Müller, Asger Sand Paludan-Müller, Andreas Lundh, Andreas Lundh, Matthew J Page, ...

Publish Year: 2021

DA: 95 PA: 81 MOZ Rank: 59

fda.gov

https://www.fda.gov/drugs/news-events-human-drugs/fdas-approval-veklury-remdesivir-treatment-covid-19-science-safety-and-effectiveness

Possible side effects include: increased levels of liver enzymes, which may be a sign of liver injury; and allergic reactions, which may include changes in blood pressure and heart rate, low …

DA: 28 PA: 70 MOZ Rank: 22

gilead.com

https://www.gilead.com/news-and-press/press-room/press-releases/2022/4/veklury-remdesivir-is-first-and-only-approved-treatment-for-pediatric-patients-under-12-years-of-age-with-covid19

Apr 25, 2022 · FOSTER CITY, Calif.-- (BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved a …

DA: 2 PA: 46 MOZ Rank: 55

cdc.gov

https://www.cdc.gov/coronavirus/2019-ncov/your-health/treatments-for-severe-illness.html

Apr 29, 2022 · Several options are available for treating COVID-19 at home or in an outpatient setting. They include: Treatment Who When How Nirmatrelvir with Ritonavi (Paxlovid) …

DA: 15 PA: 32 MOZ Rank: 70

mayoclinic.org

https://www.mayoclinic.org/diseases-conditions/coronavirus/expert-answers/coronavirus-drugs/faq-20485627

Jun 11, 2022 · The FDA has approved an antiviral drug called remdesivir (Veklury) to treat COVID-19 in adults and children who are age 12 and older. Remdesivir may be prescribed …

DA: 16 PA: 2 MOZ Rank: 16

nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836944/

Jan 29, 2021 · It should also be mentioned that in a different study remdesivir was reported to be less effective in patients hospitalized with moderate COVID-19 pneumonia (pulmonary …

DA: 60 PA: 93 MOZ Rank: 6